Loading…

Quantifying mutated and unmutated BCR-ABL transcripts confirms suitability of direct sequencing sensitivity in mutation analysis of patients with chronic myeloid leukemia with secondary resistance to tyrosine kinase inhibitors, regardless of ratio values

Saved in:

Bibliographic Details
Published in:	Leukemia & lymphoma 2010-02, Vol.51 (2), p.350-354
Main Authors:	Santamaría, Iñigo, Payer, Angel R., Pitiot, Ana S., Alvarado, Marta G., Balbín, Milagros
Format:	Article
Language:	English
Subjects:	DNA Mutational Analysis - methods Drug Resistance, Neoplasm - genetics Fusion Proteins, bcr-abl - genetics Humans Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics Mutation Protein Kinase Inhibitors - therapeutic use
Citations:	Items that this one cites
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!